Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : medical conference

Energenesis Biomedical Co., Ltd. to Present DFU Therapy at EWMA 2026

Energenesis Biomedical Co., Ltd. to Present DFU Therapy at EWMA 2026
04/29/2026 | Companies
Energenesis Biomedical Co., Ltd, a clinical-stage biotech company developing therapies aimed at restoring cellular energy, has announced that it will showcase clinical application data for its investigational treatment ENERGI-F703DFU at the European Wound Management Association 2026 Annual...
biopharmaceutical company, Bremen Germany, cellular energy restoration, chronic wound care, clinical case sharing, clinical-stage biotech, DFU treatment, diabetic foot ulcers, Energenesis Biomedical, ENERGI-F703DFU, European Wound Management Association, EWMA 2026, healthcare innovation, investigational drug, medical conference, regenerative medicine, topical drug, ulcer treatment, wound closure, wound healing

Jazz Pharmaceuticals Showcases Epilepsy and Narcolepsy Research at AAN 2026

Jazz Pharmaceuticals Showcases Epilepsy and Narcolepsy Research at AAN 2026
04/09/2026 | Companies
Jazz Pharmaceuticals plc announced that it will share six research abstracts—including one oral presentation—at the 2026 American Academy of Neurology (AAN) Annual Meeting, scheduled for April 18–22, 2026, in Chicago. These presentations highlight the scope of Jazz’s neuroscience work across...
AAN 2026, American Academy of Neurology, behavioral symptoms, cannabidiol, clinical research, cognitive function, Dravet syndrome, drug development, DUET study, EpiCom study, Epidiolex, epilepsy, Jazz Pharmaceuticals, Lennox-Gastaut syndrome, medical conference, narcolepsy, neurological disorders, neuroscience, patient care, Phase 3 trial, rare diseases, refractory epilepsy, sleep disorders, treatment outcomes, tuberous sclerosis complex, Xywav


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com